mdlinx mdlinx

Internal Medicine - Hematology/Oncology News & Articles

What makes MDLinx Internal Medicine different from all the other primary care literature reviews? Our team of medical editors read over 2,000 medical journals every day so you can stay current in less than 5 minutes! They sort, rank and summarize every article that will impact your daily practice. They even mark which articles are available in free full text, which are clinical or evidence-based, and which have MDLinx Exclusive Author Commentary from the people who actually performed the research.

Also on this page you’ll see bonus content from our physician editor, D. Scott Cunningham, MD, PhD, in the form of his top highlights you can’t miss, along with clinical pearls from The Smartest Internist, a quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education.

Your Unread Messages in Internal Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Internal Medicine!

Articles

Latest (20) Full Text Articles (1465) Focus on Thyroid Disease
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

21 Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer Journal of Clinical Oncology, May 23, 2013    Clinical Article

22 Phase III randomized, placebo-controlled study of cetuximab plus brivanib alaninate versus cetuximab plus placebo in patients with metastatic, chemotherapy-refractory, wild-type k-ras colorectal carcinoma Journal of Clinical Oncology, May 23, 2013    Clinical Article

23 Nanoparticle albumin-bound paclitaxel for second-line treatment of metastatic urothelial carcinoma: a single group, multicentre, phase 2 study The Lancet Oncology, May 23, 2013    Clinical Article

24 Nonsteroidal anti-inflammatory drug use, chronic liver disease, and hepatocellular carcinoma Hepatology, May 23, 2013    Clinical Article

25 Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia Core Evidence, May 23, 2013    Clinical Article

26 Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? Journal of Cancer Survivorship, May 23, 2013    Review Article

27 Treatment of patients with dual hepatitis C and B by peginterferon {alpha} and ribavirin reduced risk of hepatocellular carcinoma and mortality Gut, May 23, 2013    Clinical Article

28 Macrophage polarization at the crossroad between HIV-1 infection and cancer development Arteriosclerosis, Thrombosis, and Vascular Biology, May 23, 2013    Review Article

29 How long will it take to reduce gastric cancer incidence by eradicating Helicobacter pylori infection? Cancer Prevention Research, May 23, 2013    Clinical Article

30 Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: Characterization of survival outcome and application of the international mRCC database consortium criteria Cancer, May 23, 2013    Review Article

31 Employment challenges for cancer survivors Cancer, May 23, 2013    Review Article

32 Hemangioma: clinical course, complications, and management British Journal of Dermatology, May 23, 2013    Review Article

33 Using the epigenetic field defect to detect prostate cancer in biopsy negative patients The Journal of Urology, May 23, 2013    Clinical Article

34 Impact of Resistance Training in Cancer Survivors: a Meta-analysis Medicine and Science in Sports and Exercise, May 23, 2013    Evidence Based Medicine

35 Physical activity and lower limb lymphedema among uterine cancer survivors Medicine and Science in Sports and Exercise, May 23, 2013    Evidence Based Medicine

36 Causes of death in men with prostate cancer: an analysis of 50,000 men from the thames cancer registry BJU International, May 23, 2013    Clinical Article

37 Clinical performance of serum isoform [-2]propsa (p2psa) and its derivatives, namely %p2psa and phi (prostate health index), in men with a family history of prostate cancer. Results from a multicentre European study (prometheus project) BJU International, May 23, 2013    Clinical Article

38 False negative fecal occult blood test may be associated with increased mortality from colorectal cancer Digestive Diseases and Sciences, May 23, 2013    Clinical Article

39 Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis Carcinogenesis, May 23, 2013    Review Article

40 Palmar fasciitis and polyarthritis syndrome in pancreatic carcinoma JCR: Journal of Clinical Rheumatology, May 23, 2013

50 available pages First Previous 2 3 4 5 6 7 8 9 10 11 Next Last

Clinical Pearls in Internal Medicine

Highlights in Internal Medicine

Vitamin D deficiency is associated with increased mortality in ICU patients

Among 130 patients requiring mechanical ventilation, 107 were vitamin D-deficient (< 20 ng/ml). Of the patients who did not survive, the length of survival was shorter in the vitamin D-deficient patients (15.3 vs. 24.2 days, respectively).

Read the article summary

Coronary artery calcium increases cardiovascular risk in patients with T2DM and HTN

Researchers at Tel-Aviv University have conducted a study to determine the value of coronary artery calcium (CAC) measurements in cardiovascular risk stratification in patients with T2DM and HTN. The study involved 423 patients enrolled in the International Nifedipine Study: Intervention as Goal for Hypertension Therapy. The patients had baseline CT scans for CAC measurement at baseline and were shown to be free of disease. Follow-up CT scans were performed at 3 and 15 years. Cardiovascular events (CVEs) occurred in 41 of 423 patients at 3 years and 111 of 268 patients at 15 years of follow-up. CVEs occurred in 15% and 52% (CAC+) and 7% and 32% (CAC-) of patients with T2DM at 3 and 15 years of follow-up, respectively. Compared to patients without T2DM and no CAC, the HRs for a CVE were 6.6 and 3.9 in T2DM patients with and without CAC, respectively.

Read the article summary

CAC scores add predictability to Framingham

Researchers at Erasmus University Medical Center in Rotterdam have evaluated 12 measures (N-terminal fragment of prohormone B-type natriuretic peptide levels, von Willebrand factor antigen levels, fibrinogen levels, chronic kidney disease, leukocyte count, C-reactive protein levels, homocysteine levels, uric acid levels, coronary artery calcium [CAC] scores, carotid intima–media thickness, peripheral arterial disease, and pulse wave velocity), in addition to Framingham risk scores for predicting coronary heart disease. Only the CAC was shown to add significantly to the Framingham risk score in predicting coronary heart disease.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Internal Medicine Articles

Last month's top read Top Articles of 2012

1 New Perspectives of Curcumin in Cancer Prevention Cancer Prevention Research, April 17, 2013    Review Article

2 Leukaemia update. Part 1: diagnosis and management British Medical Journal, April 9, 2013    Review Article

3 Treatment of Iron-deficiency Anemia in Patients with Subclinical Hypothyroidism American Journal of Medicine, April 18, 2013

4 Statin use and risk of prostate cancer and high-grade prostate cancer: results from the REDUCE study Prostate Cancer & Prostatic Diseases, April 11, 2013

5 Enalapril And Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients with Malignant Hemopathies. The OVERCOME Trial JACC - Journal of the American College of Cardiology, April 12, 2013

6 Iron deficiency in chronic heart failure: An international pooled analysis American Heart Journal, April 1, 2013

7 The changing paradigm of CLL management European Journal of Internal Medicine , April 17, 2013    Review Article

8 Efficacy and safety of dabigatran etexilate and warfarin in real world patients with atrial fibrillation: A prospective nationwide cohort study JACC - Journal of the American College of Cardiology, April 15, 2013

9 Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study British Medical Journal, April 23, 2013

10 The role of Helicobacter pylori infection in hematological disorders European Journal of Internal Medicine , March 29, 2013    Review Article

11 Red flags to screen for malignancy in patients with low-back pain Cochrane Reviews, March 8, 2013

12 Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013 Mayo Clinic Proceedings, April 9, 2013    Free full text    Clinical Guideline

13 Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality European Urology, March 27, 2013    Free full text

14 Cervical cancer screening: What’s new and what’s coming? Cleveland Clinic Journal of Medicine, March 19, 2013

15 Effective elimination of dabigatran by haemodialysis Thrombosis and Haemostasis, April 12, 2013

16 Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly The Lancet Oncology, May 10, 2012

17 The impact of coffee on health Maturitas, February 26, 2013

18 MicroRNA Profiling Can Classify Acute Leukemias of Ambiguous Lineage as Either Acute Myeloid Leukemia or Acute Lymphoid Leukemia Clinical Cancer Research, April 9, 2013

19 Ideal Cardiovascular Health Is Inversely Associated With Incident Cancer Circulation, March 27, 2013

20 Thromboprophylaxis for trauma patients Cochrane Reviews, April 1, 2013    Review Article

Indexed Journals in Internal Medicine: New England Journal of Medicine, The Lancet, Archives of Internal Medicinemore

Other Topics in Internal Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close